A Phase I study of irinotecan, bevacizumab and TAS-102 for metastatic colorectal cancer patients
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: Medication Primary outcome(s): Dose limiting toxicity Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
创建时间：
2016-10-15
